PAR
Click for more information
2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm’s Secondary Endpoints Successfully Met, page-49

  1. PZ99
    292 Posts.
    lightbulb Created with Sketch. 110
    clock Created with Sketch.
    17/04/19
    10:08
    Post #: 38175674
    Thanks Mozzarc. I'll check it out. Sounds like Pentosan could be the new aspirin

    PAR Price at posting: $1.78 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
SXG Southern Cross finds large gold-antimony zone underneath historic Victorian mine
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
WGX Mining start at South Junction adds to Westgold's hopes for WA gold complex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢ 		Change
0.005(2.17%) 		Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.